Stepan (SCL) Projected to Post Quarterly Earnings on Tuesday

Stepan (NYSE:SCL) is expected to be announcing its Q1 2026 results before the market opens on Tuesday, April 28th. Analysts expect the company to announce earnings of $0.44 per share and revenue of $612.95 million for the quarter. Investors are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Tuesday, April 28, 2026 at 8:00 AM ET.

Stepan (NYSE:SCL) last issued its quarterly earnings data on Monday, February 23rd. The basic materials company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.37). The business had revenue of $553.89 million for the quarter, compared to analyst estimates of $570.60 million. Stepan had a return on equity of 3.38% and a net margin of 2.01%.The business’s quarterly revenue was up 5.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.12 earnings per share. On average, analysts expect Stepan to post $2 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Stepan Stock Performance

Shares of NYSE SCL opened at $51.92 on Friday. The company has a current ratio of 1.29, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The stock has a 50 day simple moving average of $51.32 and a 200-day simple moving average of $49.88. The company has a market cap of $1.18 billion, a PE ratio of 25.33 and a beta of 1.01. Stepan has a 12-month low of $41.82 and a 12-month high of $68.00.

Stepan Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Monday, March 2nd were paid a dividend of $0.395 per share. This represents a $1.58 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date was Monday, March 2nd. Stepan’s dividend payout ratio (DPR) is currently 77.07%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Weiss Ratings lowered shares of Stepan from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 4th. Zacks Research lowered shares of Stepan from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 4th. Two research analysts have rated the stock with a Sell rating, According to data from MarketBeat, Stepan presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Entropy Technologies LP acquired a new position in shares of Stepan during the fourth quarter valued at approximately $270,000. Corient Private Wealth LLC acquired a new position in Stepan in the second quarter worth approximately $248,000. Cerity Partners LLC acquired a new position in Stepan in the second quarter worth approximately $241,000. PharVision Advisers LLC acquired a new position in Stepan in the third quarter worth approximately $231,000. Finally, Mercer Global Advisors Inc. ADV acquired a new position in Stepan in the fourth quarter worth approximately $224,000. Institutional investors and hedge funds own 82.70% of the company’s stock.

About Stepan

Stepan Company is a global manufacturer of specialty and intermediate chemicals, primarily known for its development and production of surfactants and related specialty products. The company’s portfolio includes a wide range of ingredients used to enhance the performance of consumer and industrial formulations, such as emulsifiers, foam control agents, odor control agents, antimicrobial products and performance additives. These products are integral components in cleaning solutions, personal care items, agrochemical formulations, coatings, oilfield treatments and polymer systems.

Serving a diverse set of end-markets, Stepan’s offerings address both consumer-facing and industrial applications.